MGX

Metagenomi Therapeutics, Inc. - Common Stock (MGX)

About Metagenomi Therapeutics, Inc. - Common Stock (MGX)

Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Details

Daily high
$1.01
Daily low
$0.96
Price at open
$1.00
52 Week High
$3.95
52 Week Low
$0.96
Market cap
37.2M
Dividend yield
-
Volume
354,862
Avg. volume
148,579
P/E ratio
-.40

Metagenomi Therapeutics, Inc. - Common Stock News

Details

Daily high
$1.01
Daily low
$0.96
Price at open
$1.00
52 Week High
$3.95
52 Week Low
$0.96
Market cap
37.2M
Dividend yield
-
Volume
354,862
Avg. volume
148,579
P/E ratio
-.40